Neon Therapeutics, Inc.

Home » Neon Therapeutics, Inc.

IPO

Neon Therapeutics, Inc.

We are a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens.

Symbol

NTGN

Price Range
$15.00 - $17.00

Final Shares
6,250,000

Anticipated Date
TBD

Underwriters
MORGAN STANLEY, BofA MERRILL LYNCH, MIZUHO SECURITIES, OPPENHEIMER & Co.

To view the prospectus for Neon Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253